The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc.

A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

At its February midyear meeting, the American Bar Association passed a resolution that urges the United States and other national governments to "promote the development and use of methods that aim to ...